Ondansetron Tablets

Type of Posting: 
Revision Bulletin
Official Date: 
01–Mar–2010
Expert Committee: 
Biopharmaceutics

In accordance with the Rules and Procedures of the 2005–2010 Council of Experts, the Biopharmaceutics Expert Committee has revised the Ondansetron Tablets monograph to include a Dissolution Test 4 for a recently approved generic version.

The Ondansetron Tablets Revision Bulletin supersedes the currently official monograph and will be incorporated in the Second Supplement to the USP 33–NF 28 Reissue.

Should you have any questions, please contact Margareth Marques (301-998-6789 or mrm@usp.org).